Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.
暂无分享,去创建一个
[1] B. Goldman. Melanoma and tumor thickness. , 2000, Archives of Dermatology.
[2] D. Lipsker,et al. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. , 1999, Archives of dermatology.
[3] D. English,et al. Melanoma in the elderly — a neglected public health challenge , 1999, The Medical journal of Australia.
[4] J. Grob,et al. Melanoma and tumor thickness: challenges of early diagnosis. , 1999, Archives of dermatology.
[5] L. Dennis,et al. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. , 1999, Archives of dermatology.
[6] D. English,et al. Nodular histogenetic type--the most significant factor for thick melanoma: implications for prevention. , 1998, Melanoma research.
[7] R. Gallagher,et al. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.
[8] J. Kelly,et al. Melanoma in the elderly ‐a neglected public health challenge , 1998, The Medical journal of Australia.
[9] P. Hersey,et al. Factors involved in presentation of older people with thick melanoma , 1998, The Medical journal of Australia.
[10] U. Ringborg,et al. Nodular histogenetic type – the most significant factor for thick melanoma: implications for prevention , 1998, Melanoma research.
[11] J Cuzick,et al. Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.
[12] J. Hunter,et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94 , 1997, BMJ.
[13] U. Ringborg. Review: Cutaneous Malignant Melanoma , 1996 .
[14] E. Nicolaidou,et al. Cutaneous malignant melanoma and sun exposure. Recent developments in epidemiology. , 1998, Archives of dermatology.
[15] G. Giles,et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 , 1996, BMJ.
[16] R. Swerlick,et al. The melanoma epidemic. Is increased surveillance the solution or the problem? , 1996, Archives of dermatology.
[17] Gernot Rassner,et al. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients , 1995, Cancer.
[18] U. Chetty,et al. Cutaneous malignant melanoma. Publicity, screening clinics and survival—the Edinburgh experience 1982–90 , 1995, The British journal of dermatology.
[19] C. Luke,et al. Trends in prognostic factors of melanoma in South Australia, 1981–1992: implications for health promotion , 1995, The Medical journal of Australia.
[20] H. Adami,et al. Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. , 1994, British Journal of Cancer.
[21] R. Burton,et al. Recent incidence trends imply a nonmetastasizing form of invasive melanoma , 1994, Melanoma research.
[22] P. Hersey,et al. An analysis of a melanoma epidemic , 1993, International journal of cancer.
[23] J C Briggs,et al. Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.
[24] N. Martin,et al. Increasing incidence of cutaneous melanoma in Queensland, Australia. , 1992, Journal of the National Cancer Institute.
[25] R. MacKie,et al. Melanoma in people aged 65 and over in Scotland, 1979-89. , 1992, BMJ.
[26] P. Hersey,et al. Factors related to the presentation of patients with thick primary melanomas , 1991, The Medical journal of Australia.
[27] R. Marks,et al. DO ALL MELANOMAS COME FROM “MOLES”? A STUDY OF THE HISTOLOGICAL ASSOCIATION BETWEEN MELANOCYTIC NAEVI AND MELANOMA , 1990, The Australasian journal of dermatology.
[28] A. Kopf,et al. Age and malignant melanoma: comparison of variables in different age-groups. , 1989, Journal of the American Academy of Dermatology.
[29] C. D. Taylor. Malignant melanoma in the elderly. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] A. Kopf,et al. Thickness of malignant melanoma: global analysis of related factors. , 1987, The Journal of dermatologic surgery and oncology.
[31] D. English,et al. MELANOMA IN WESTERN AUSTRALIA IN 1980‐81: INCIDENCE AND CHARACTERISTICS OF HISTOLOGICAL TYPES , 1987, Pathology.
[32] A. Cochran,et al. The Classification of Malignant Melanoma, its Histological Reporting and Registration: A Revision of the 1972 Sydney Classification , 1986, Pathology.
[33] R. MacKie,et al. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population , 1985, The British journal of dermatology.
[34] A. Green,et al. Cutaneous malignant melanoma in association with other skin cancers. , 1985, Journal of the National Cancer Institute.
[35] B K Armstrong,et al. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. , 1984, Journal of the National Cancer Institute.
[36] Heenan Pj,et al. Nodular malignant melanoma: a distinct entity or a common end stage? , 1982 .
[37] C. Holman,et al. Nodular malignant melanoma: a distinct entity or a common end stage? , 1982, American journal of dermatopathology.
[38] K. Kupka,et al. International classification of diseases: ninth revision. , 1978, WHO chronicle.
[39] J. Hunter. CUTANEOUS MALIGNANT MELANOMA , 1976, International journal of dermatology.
[40] W. Clark,et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.